Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
HonorHealth, Scottsdale, Arizona City of Hope National Medical Center, Duarte, California University of Chicago, Chicago, Illinois Corewell Health-BAMF Health, Grand Rapids, Michigan Memorial Sloan- Kettering Cancer Center, New York, New York Case Western Reserve University, Cleveland, Cleveland, Ohio UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania University of Wisconsin-Madison, Madison, Wisconsin